Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5

Koichi Hashimoto1, Barney S Graham, Samuel B Ho

  • 1Vanderbilt University, School of Medicine, Nashville, Tennessee 37232, USA.

Insights

Respiratory syncytial virus (RSV) infection combined with allergic inflammation significantly increases airway mucus production. This exacerbates asthma-like symptoms and airway hyperresponsiveness in mice.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Molecular Biology

Background:

  • Respiratory syncytial virus (RSV) is linked to childhood asthma and wheezing.
  • Previous studies show RSV infection prolongs airway hyperresponsiveness in sensitized mice.

Purpose of the Study:

  • To investigate the mechanisms behind increased mucus production in allergically sensitized mice infected with RSV.
  • To explore the role of Muc5ac, gob-5, and interleukin-17 in RSV-associated mucus production.

Main Methods:

  • Ovalbumin (OVA)-sensitized mice were infected with RSV.
  • Histochemical analysis and Western blot were used to assess Muc5ac and gob-5 expression.
  • Lung levels of interleukin-17 were measured.

Main Results:

  • OVA/RSV mice showed significantly increased Muc5ac and gob-5 expression in airways compared to controls.
  • Airway mucus production was markedly higher in OVA/RSV mice.
  • Increased interleukin-17 levels were observed in the lungs of OVA/RSV mice.

Conclusions:

  • Combined RSV infection and allergic inflammation drive significant airway mucus production.
  • Muc5ac and gob-5 are key mediators of this mucus overproduction.
  • Interleukin-17 contributes to the enhanced mucin gene expression.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...